Healthcare M&A and Valuation
News and Insights

On August 15, 2025, Cardinal Health (NYSE: CAH)  announced its acquisition  of Solaris Health, the leading urology‑focused management services organization (MSO) in the U.S., in a strategic transaction valued at approximately $1.9 billion in cash consideration, with additional equity rollover bringing implied total deal value closer to $2.4 billion. The deal expands Cardinal’s multi‑specialty MSO platform, The Specialty Alliance, by adding more than 750 providers across 250+

The hospice industry plays a critical role in the U.S. healthcare system, providing compassionate, end-of-life care to patients with terminal illnesses. Hospice services include pain management, symptom relief, counseling, and support for both patients and their families. The industry is heavily regulated and deeply influenced by reimbursement policy, but it continues to be a highly active sector for M&A, driven by demographic tailwinds and the ongoing aging of the U.S. popul

On August 1, 2025, ATI Physical Therapy, Inc. (OTC: ATIP), a leading U.S. provider of outpatient physical therapy and rehabilitation services operating hundreds of clinics across more than 20 states, transitioned from  a publicly traded company to private ownership through a merger led by existing stockholders and private investment firms Knighthead Capital Management and Marathon Asset Management. Under the definitive merger agreement, stockholders not affiliated with the in

In July 2025, Aurobindo Pharma USA Inc., the wholly owned U.S. subsidiary of Indian generics manufacturer Aurobindo Pharma Ltd., entered into a definitive agreement  to acquire Lannett Co., Inc., a U.S. based producer of complex generic pharmaceuticals, for an enterprise value of approximately $250 million on a cash‑free, debt‑free basis. The transaction, which is expected to close within 8–12 months pending regulatory approvals, will provide Aurobindo with full ownership of